With a forthcoming nonfiction book and an online army of Nerdfighters, the young-adult author aims...
Author - David Miller
STAT+: VCs move to launch U.S.-based companies to advance drugs...
As Chinese biopharma companies rise on the international stage, they are increasingly finding VC...
Opinion: I’m the director of the Center for Medicare. Here’s...
The historic Inflation Reduction Act of 2022 has fundamentally improved the affordability of and...
Opinion: Fecal transplants are saving lives — but are now at...
Twenty years ago, a respected colleague asked me to perform a “poop transplant” on a local...
Q&A: Why drafting new rules on ultra-processed foods is so...
Ultra-processed foods are part of daily life, filling 60% to 70% of the American diet. That...
STAT+: Dreams of cancer vaccines are becoming more real. Here...
Vaccines are the original immunotherapy, in the view of Ryan Sullivan, a cancer immunotherapy...
STAT+: Pfizer beats earnings expectations in first report after...
Pfizer released earnings Tuesday that handily beat analyst expectations in the company’s first...
GSK acquires autoimmune drug candidate
This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s...
Lassa fever, eviction lawyers, ultra-processed foods, and poop...
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning...
STAT+: Pharmalittle: We’re reading about Charles River monkey...
Top of the morning to you and a fine one it is. Blue skies, cool breezes, and plenty of chirping...